- A complete remission can be achieved despite persistence of abnormal bone marrow promyelocytes in acute promyelocytic leukemia: experience in 2 patients
-
Kim SW, Lee KH, Lee JS, Suh C, Ahn MJ, Kim SW, Chi HS, Kim SH
- KMID: 2157506
- J Korean Med Sci.
- 1993 Aug;8(4):246-250.
- doi: 10.3346/jkms.1993.8.4.246
Acute promyelocytic leukemia (APL) is a distinct subset of acute myeloid leukemia (AML) and is distinguished from other subsets of AML by its distinctive morphology, specific chromosomal abnormality, associated consumptive... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Adalimumab in Korean Patients with Crohn's Disease
-
Sohn IW, Kim ST, Kim B, Lee HJ, Park SJ, Hong SP, Kim TI, Kim WH, Cheon JH
- KMID: 2363971
- Gut Liver.
- 2016 Mar;10(2):255-261.
- doi: 10.5009/gnl15165
BACKGROUND/AIMS: Adalimumab is effective for both remission induction and the maintenance of Crohn's disease (CD) in Western countries. We evaluated the efficacy of adalim-umab in the conventional step-up treatment approach... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and Safety of Adalimumab in Moderately to Severely Active Cases of Ulcerative Colitis: A Meta-Analysis of Published Placebo-Controlled Trials
-
Zhang ZM, Li W, Jiang XL
- KMID: 2363972
- Gut Liver.
- 2016 Mar;10(2):262-274.
- doi: 10.5009/gnl15042
BACKGROUND/AIMS: To evaluate the efficacy and safety of adalimumab (ADA) in moderately to severely active ulcerative colitis (UC) patients who are unresponsive to traditional therapy. METHODS: Electronic databases, including the PubMed,... -
- CITED
-
- Close
- SHARE
-
- Close
